What is the effectiveness of standard chemotherapy regimens for the treatment of acute myeloid leukemia (AML)?

Updated: May 26, 2020
  • Author: Karen Seiter, MD; Chief Editor: Emmanuel C Besa, MD  more...
  • Print

Current standard chemotherapy regimens cure only a minority of patients with AML. Consequently, all patients should be evaluated for entry into well-designed clinical trials. If a clinical trial is not available, the patient can be treated with standard therapy. (See Treatment.) Readmission is frequently required for the management of toxic effects of chemotherapy.

Go to Oncology Decision Point for expert commentary on AML treatment decisions and related guidelines.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!